Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra

Brain Research

Volumn 888, Issue 2, 2001, Pages 336-342

  Costa, Gustavo ^a   Abin Carriquiry, J A ^a   Dajas, Federico ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

Author keywords

6 Hydroxydopamine; Chlorisondamine; Corpus striatum; Dopamine; Nicotine; Nicotinic acetylcholine receptor; Substantia nigra

Indexed keywords

CHLORISONDAMINE; DOPAMINE; NICOTINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DRUG ANTAGONISM; MALE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CHLORISONDAMINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, SUBCUTANEOUS; MALE; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0035847204     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03087-0     Document Type: Article

References (44)

1. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamatecyto toxicity
2. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
3. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: Implications for behavioral recovery from brain injury
4. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions
5. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
6. The nicotinic receptor agonist epibatidine increases FGF-2 mRNA and protein levels in the rat brain
7. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat
8. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
9. Chronic continue infusion of (-) nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat
10. Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway
11. Dopamine and nicotine receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
12. Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation
13. Alpha nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca dependent mechanism
14. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA) ABT-418
15. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administrated in vivo
16. 3H]chlorisondamine
17. Effects of nicotine on hydroxyl free radial formation in vitro and on MPTP-induced neurotoxicity in vivo
18. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration
19. Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice
20. Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurones
21. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydoxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro
22. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurones from 6-hydroxydopamine toxicity: Involvement of the Glutathion system
23. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male after partial hemitransection
24. Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurones in the male rat
25. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse
26. 6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death
27. Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity
28. Free radical-generated neurotoxicity of 6-hydroxydopamine
29. Characterization of the neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells
30. Dopamine, 6-hydoxydopamine, iron, and dioxygen - Their mutual interactions and possible implication in the development of Parkinson's disease
31. Neuronal nicotinic acetylcholine receptors as novel drug targets
32. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
33. Nicotine protects cultured striatal neurons against N-methyl-D-aspartate receptor-mediated neurotoxicity
34. A retrospective study of smoking in Parkinson's disease
35. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells
36. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system
37. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle
38. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model
39. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors
40. Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage
41. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity